Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03022929 · ClinicalTrials.gov registry record · NA

A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings

A NA study, sponsored by University of California, Davis.

Completed
Registry status
NA
Development phase
257
Enrollment target

NCT03022929 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 257 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03022929, a NA study, has completed, sponsored by University of California, Davis.

COMPLETED
Registry status
NA
Development phase
257 participants
Enrollment target

Study Summary

Inappropriate antibiotic use is a major public health concern. Excessive exposure to antibiotics results in emergence and spread of drug-resistant bacteria, potentially avoidable adverse drug reactions, and increased healthcare utilization and cost. As antibiotic prescribing in emergency departments and urgent care centers remains unchecked, national professional organizations including the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology (SHEA), and an Executive Order from the President of the United States, recommend expansion of antimicrobial stewardship to these ambulatory care settings. The goal of antimicrobial stewardship is to effectively promote judicious antibiotic use in all healthcare settings, yet stewardship programs have not achieved their potential in terms of either reach or effectiveness. Reach has been limited by implementation mostly in inpatient settings; at the same time, recent critical experiments in behavioral science suggest that the effectiveness of existing stewardship programs could be greatly augmented through inclusion of behavioral nudges, benchmarked audit and feedback, and peer-to-peer comparisons.

Interventions

  • BEHAVIORAL Enhanced Antimicrobial Stewardship Commitment and Feedback

Trial Details

FieldValue
Enrollment Target 257 participants
Start Date 2017-01
Est. Completion 2018-09-24
Phase NA

Sponsor

University of California, Davis

657 total trials

What the Registry Record Tells You About NCT03022929

The ClinicalTrials.gov registry entry for NCT03022929 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Enhanced Antimicrobial Stewardship Commitment and Feedback is the first listed.

NCT03022929 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03022929 about?

NCT03022929 is a clinical study titled "A Multifaceted Intervention to Improve Prescribing for Acute Respiratory Infection for Adults and Children in Emergency Department and Urgent Care Settings". Inappropriate antibiotic use is a major public health concern. Excessive exposure to antibiotics results in emergence and spread of drug-resistant bacteria, potentially avoidable adverse drug reactions, and increased healthcare utilization and cost. As antibiotic prescribing in emergency departments...

What is the current status of trial NCT03022929?

This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2017-01. Estimated completion is 2018-09-24.

What interventions are being tested in trial NCT03022929?

The interventions under investigation include: Enhanced Antimicrobial Stewardship Commitment and Feedback (BEHAVIORAL).

Who is sponsoring clinical trial NCT03022929?

This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.